capital area physical therapy, pLLC

7 hemphill place
suite 130
malta, new york 12020

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 03, 2013

NYS DOS ID#
4411915

County
SARATOGA

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY

Name History
2013 - CAPITAL AREA PHYSICAL THERAPY, PLLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Bots are becoming highly skilled assistants in physical therapy
    By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017

    Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence.  Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]

    Source: VentureBeat
  • Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups
    By David Holley - Wednesday Jul 26, 2017

    Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at the specialty accelerator’s sixth cohort, which includes a company named for a butterfly and the accelerator’s first digital health startup. Illumina (NASDAQ: ILMN), […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Bomb Kills Panama Papers Reporter, Malta Leader Says
    By Associated Press - Monday Oct 16, 2017

    An explosion killed a investigative journalist who exposed the connections of Malta's prime minister to tax havens using the Panama Papers.

    Source: NBC News
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York